The prenatal diagnostics industry is  expected to reach $3.6 billion by 2019 with the demand for prenatal tests tripling over  the next six years. [Mopic/Fotolia]

A Crowded Field for Noninvasive Prenatal Screening Tests

Prenatal screening for detection of a wide range of monogenic disorders and chromosomal abnormalities has been available to prospective parents for over 40 years....
Source: NIH

NIH Funding Made Available to Advance Sequencing Technology

The National Human Genome Research Institute commits $6.7 million toward the development of new sequencing technologies.
Researchers at Keele University have developed SIFT-MS

Clinical Mass Spec Attains Critical Mass

Clinical applications for mass spectrometry technology have exploded in recent years. Mass spectrometry analysis is often faster, cheaper, and more sensitive than other methods...
Sequencing of RNA molecules

Could RNA Sequencing Become the Workhorse of Precision Medicine?

Advances in genomics over the past several years have had a profound impact on our grasp of molecular biology and genetics. In the laboratory, next-generation sequencing...
Source: man_at_mouse/Getty Images

Lethal Viruses Hijack DNA-Damage Response, May Be Exploited for Cancer

Henipaviruses hijack a mechanism used by cells to counter DNA damage and prevent harmful mutations, important in diseases such as cancer
Source: UC San Diego Health

RNA Biomarkers and Splicing Help Identify and Target Secondary Leukemia

Discovery involves secondary AML, which particularly afflicts older patients and has poor prognoses.
Source: PeopleImages/Getty Images

Genes Responsible for Extreme Form of Morning Sickness Identified

UCLA researchers say two genes involved in placental development and appetite regulation are associated with hyperemesis gravidarum (HG)
Source: iStock/fatido

Costs of Genome Sequencing in the Clinic Tend to Peak Early

When genomic sequencing is added to a patient’s care, the initial costs can be considerable, but they don’t appear to climb over time. For...
One of the goals of the Prenatal Quality Foundation’s campaign is to close knowledge gaps among consumers and healthcare providers about novel noninvasive prenatal screening tests. [iStock/© EmiliaU]

Initiative Aims to Advance Clinically Appropriate Noninvasive Prenatal Screening

The Perinatal Quality Foundation (PQF) has begun a nationwide campaign to improve understanding of the advantages, limitations, and clinically appropriate interpretation of results of...
Appistry's CSO Richard Mazzarella

VIEW NOW—Clinically Actionable Genomics: From Sequencing to Personalized Medicine

The DxMA webcast "Clinically Actionable Genomics: From Sequencing to Personalized Medicine" sponsored by Clinical OMICs is now available for viewing. This webcast focuses on describing...
Scroll Up